The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

15 articles for P Dokurno


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution.EBI
Vernalis (R&D)
Structure-guided design of alpha-amino acid-derived Pin1 inhibitors.EBI
Vernalis (R&D)
Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureas.EBI
Vernalis (R&D)
A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinase.EBI
Daiichi Sankyo Co.
Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors.EBI
Servier Research Institute of Medicinal Chemistry
Design and Synthesis of Pyrrolo[2,3-EBI
Vernalis (R&D)
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B.EBI
Vernalis (R&D)
Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor.EBI
Servier Research Institute of Medicinal Chemistry
Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity.EBI
Servier Research Institute of Medicinal Chemistry
Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1).EBI
Vernalis (R&D)
RORγ modulatorsBDB
Bristol-Myers Squibb
Diacylglycerol acyl transferase 2 inhibitorsBDB
Pfizer
Substituted pyridine derivatives useful as c-fms kinase inhibitorsBDB
Janssen Pharmaceutica
Triazine Compounds as Antagonists at Bv8-Prokineticin Receptors.BDB
University of Ferrara
Synthesis and structure-activity relationships of pyrazine-pyridine biheteroaryls as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors.BDB
Johnson & Johnson Pharmaceutical